Acadian Asset Management LLC Alector, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Alector, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 740,235 shares of ALEC stock, worth $3.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

740,235

Previous 590,662 25.32%

Holding current value

$3.63 Million

Previous $2.68 Million 28.57%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.34 - $6.58 $649,146 - $984,190	149,573 Added 25.32%	740,235 $3.45 Million
Q2 2024 Aug 06, 2024	BUY	$4.19 - $6.23 $611,802 - $909,673	146,015 Added 32.84%	590,662 $2.68 Million
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $1.72 Million - $2.44 Million	301,936 Added 211.57%	444,647 $2.68 Million
Q4 2023 Feb 13, 2024	SELL	$3.77 - $8.39 $39,792 - $88,556	-10,555 Reduced 6.89%	142,711 $1.14 Million
Q3 2023 Nov 13, 2023	BUY	$5.2 - $8.77 $323,206 - $545,099	62,155 Added 68.22%	153,266 $993,000
Q2 2023 Aug 07, 2023	BUY	$5.86 - $7.93 $474,372 - $641,941	80,951 Added 796.76%	91,111 $547,000
Q1 2023 May 11, 2023	SELL	$5.85 - $9.84 $540,850 - $909,737	-92,453 Reduced 90.1%	10,160 $62,000
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $547,771 - $760,351	-79,618 Reduced 43.69%	102,613 $943,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $698,230 - $1.13 Million	85,254 Added 87.91%	182,231 $1.73 Million
Q2 2022 Aug 09, 2022	BUY	$7.65 - $14.24 $484,413 - $901,705	63,322 Added 188.15%	96,977 $985,000
Q1 2022 May 12, 2022	SELL	$13.02 - $20.78 $94,941 - $151,527	-7,292 Reduced 17.81%	33,655 $478,000
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $792,324 - $1.05 Million	40,947 New	40,947 $843,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.7M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $405M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Alector, Inc. Transaction History